검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | Rescue medications |
Overview Company | Merck Sharp & Dohme LLC |
Overview Modality | ADC |
Overview Target | Endometrial Cancer |
Overview Indication | Lung Neoplasm Malignant |
Overview Phase | PHASE_3 |
Overview Status | RECRUITING |
MoA Mechanism | inhibits the Wnt signaling pathway |
MoA Biomarker | biomarker associated with adverse clinical outcomes in HCC |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse |
PK/PD Experiment | PD |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse |
Toxicology Major finding | [Efficacy and safety of pixavir marboxil for uncomplicated influenza in adults: a phase Ⅱ, randomized, double-blind, placebo-controlled clinical trial].. Objective: To evaluate the antiviral effect, clinical efficacy, safety and tolerability of pixavir marboxil in adult patients with acute, uncomplicated influenza. Methods: This was a multicenter, randomized, double-blind, placebo-controlle… |
Clinical Data Tier / Score | A · 41 |
Clinical Program phase | PHASE_3 |
Clinical Clinical sync | 2026년 7월 9일 (5일 전) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | Rescue medications |
Overview Company | Merck Sharp & Dohme LLC |
Overview Modality | ADC |
Overview Target | Endometrial Cancer |
Overview Indication | Lung Neoplasm Malignant |
Overview Phase | PHASE_3 |
Overview Status | RECRUITING |
MoA Mechanism | inhibits the Wnt signaling pathway |
MoA Biomarker | biomarker associated with adverse clinical outcomes in HCC |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse |
PK/PD Experiment | PD |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse |
Toxicology Major finding | [Efficacy and safety of pixavir marboxil for uncomplicated influenza in adults: a phase Ⅱ, randomized, double-blind, placebo-controlled clinical trial].. Objective: To evaluate the antiviral effect, clinical efficacy, safety and tolerability of pixavir marboxil in adult patients with acute, uncomplicated influenza. Methods: This was a multicenter, randomized, double-blind, placebo-controlle… |
Clinical Data Tier / Score | A · 41 |
Clinical Program phase | PHASE_3 |
Clinical Clinical sync | 2026년 7월 9일 (5일 전) |
추천 비교
추천 비교